ADAM17 and Sepsis: Studies in sepsis animal models have shown that reducing ADAM17 expression decreases serum levels of IL-1β, IL-6, and TNF-α while also decreasing ICAM-1 and VCAM-1 expression in lung and liver tissues, thereby significantly improving 72-h survival in mice [34].